Latest Developments in Global Quantum Biotechnology Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Quantum Biotechnology Market

  • Pharmaceutical
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In January 2025, IonQ announced a 21.1 million USD project in partnership with Qubitekk, Inc. to collaborate with the United States Air Force Research Lab (AFRL). This initiative marks another major milestone for IonQ as it works with AFRL to establish quantum network infrastructure at the Innovare Advancement Center in Rome, New York. The project will support AFRL’s Quantum Information Science & Technology Branch at the Information Directorate, advancing its research in quantum networking and computing.
  • In September 2024, PsiQuantum announced plans to expand its operations in Queensland, Australia, by opening a 'Test & Characterization' lab at Griffith University's Nathan Campus in Brisbane. The lab space at Griffith’s Nathan Campus will undergo renovations, with PsiQuantum anticipating a move into the new facility in early 2025.
  • In February 2024, Xanadu received a repayable contribution from the Government of Canada, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), to support companies in advancing and commercializing their quantum products. This funding, provided through the Regional Quantum Initiative (RQI), will help accelerate the development of PennyLane, Xanadu's open-source, cloud-based software framework for quantum machine learning, quantum chemistry, and quantum computing.
  • In January 2024, Accenture announced a strategic investment through Accenture Ventures in QuantHealth, an AI-driven company that specializes in cloud-based clinical trial simulations. This investment aims to help pharmaceutical and biotech companies accelerate and reduce the costs of developing treatments for patients. QuantHealth’s clinical trial simulation platform has the potential to expedite clinical trials, enabling pharmaceutical and biotech companies to deliver life-saving treatments to patients more quickly.
  • In October 2023, Samsung Semiconductor India Research (SSIR) announced a collaboration with the Indian Institute of Science (IISc) to establish a state-of-the-art Quantum Technology Lab. This initiative aligns with SSIR's CSR commitment and is designed to offer research and training opportunities for numerous faculty members and hundreds of students pursuing higher education, both at IISc and other academic institutions.

Frequently Asked Questions